EAACI taskforce position paper: Evidence for autoimmune urticaria and proposal for defining diagnostic criteria

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 1, 2013, Pages 27-36

  Konstantinou, G N ^a   Asero, R ^b   Ferrer, M ^c   Knol, E F ^d   Maurer, M ^e   Raap, U ^f   Schmid Grendelmeier, P ^g   Skol, P S ^h   Grattan, C E H ⁱ  

^a 424 General Army Hospital   (Greece)

^b Ambulatorio di Allergologia   (Italy)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^h ODENSE UNIVERSITY HOSPITAL   (Denmark)

ⁱ NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

autoimmune urticaria; autoreactivity; basophil activation marker; histamine release assay; Witebsky's postulates

Indexed keywords

AUTOANTIBODY; CYCLOSPORIN A; OMALIZUMAB;

AUTOIMMUNE DISEASE; AUTOIMMUNE URTICARIA; BASOPHIL; CELL FUNCTION; CHRONIC URTICARIA; CLINICAL FEATURE; DISEASE CLASSIFICATION; DRUG RESPONSE; HISTAMINE RELEASE; HUMAN; MAST CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; BASOPHILS; CELL DEGRANULATION; COMPLEMENT SYSTEM PROTEINS; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN G; IMMUNOTHERAPY; MAST CELLS; RECEPTORS, IGE; URTICARIA;

EID: 84870604437     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12056     Document Type: Review

References (137)

1. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez-Arnau A, et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417-1426.
2. Rose NR, Bona C,. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993; 14: 426-430.
3. Gruber BL, Baeza ML, Marchese MJ, Agnello V, Kaplan AP,. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 1988; 90: 213-217.
4. Grattan CE, Francis DM, Hide M, Greaves MW,. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 1991; 21: 695-704.
5. Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW,. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328: 1599-1604.
6. Fiebiger E, Maurer D, Holub H, Reininger B, Hartmann G, Woisetschlager M, et al. Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? J Clin Invest 1995; 96: 2606-2612.
7. Niimi N, Francis DM, Kermani F, O'Donnell BF, Hide M, Kobza-Black A, et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996; 106: 1001-1006.
8. Tong LJ, Balakrishnan G, Kochan JP, Kinet JP, Kaplan AP,. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol 1997; 99: 461-465.
9. Ferrer M, Kinet JP, Kaplan AP,. Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol 1998; 101: 672-676.
10. Fiebiger E, Hammerschmid F, Stingl G, Maurer D,. Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest 1998; 101: 243-251.
11. Ferrer M, Nakazawa K, Kaplan AP,. Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol 1999; 104: 169-172.
12. Sabroe RA, Fiebiger E, Francis DM, Maurer D, Seed PT, Grattan CE, et al. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 2002; 110: 492-499.
13. Hidvegi B, Nagy E, Szabo T, Temesvari E, Marschalko M, Karpati S, et al. Correlation between T-cell and mast cell activity in patients with chronic urticaria. Int Arch Allergy Immunol 2003; 132: 177-182.
14. Kikuchi Y, Kaplan AP,. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 2001; 107: 1056-1062.
15. Vonakis BM, Vasagar K, Gibbons SP Jr, Gober L, Sterba PM, Chang H, et al. Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria. J Allergy Clin Immunol 2007; 119: 441-448.
16. Mozena JD, Tinana A, Negri J, Steinke JW, Borish L,. Lack of a role for cross-reacting anti-thyroid antibodies in chronic idiopathic urticaria. J Invest Dermatol 2010; 130: 1860-1865.
17. Eckman JA, Hamilton RG, Gober LM, Sterba PM, Saini SS,. Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies. J Invest Dermatol 2008; 128: 1956-1963.
18. Puccetti A, Bason C, Simeoni S, Millo E, Tinazzi E, Beri R, et al. In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation. Clin Exp Allergy 2005; 35: 1599-1607.
19. Grattan CE, D'Cruz DP, Francis DM, Whiston C, Hughes GR, Greaves MW,. Antiendothelial cell antibodies in chronic urticaria. Clin Exp Rheumatol 1995; 13: 272-273.
20. Altrichter S, Peter HJ, Pisarevskaja D, Metz M, Martus P, Maurer M,. IgE mediated autoallergy against thyroid peroxidase-a novel pathomechanism of chronic spontaneous urticaria? PLoS One 2011; 6: e14794.
21. Tedeschi A, Lorini M, Asero R,. Anti-thyroid peroxidase IgE in patients with chronic urticaria. J Allergy Clin Immunol 2001; 108: 467-468.
22. Horn MP, Pachlopnik JM, Vogel M, Dahinden M, Wurm F, Stadler BM, et al. Conditional autoimmunity mediated by human natural anti-Fc(epsilon)RIalpha autoantibodies? Faseb J 2001; 15: 2268-2274.
23. Miescher SM, Horn MP, Pachlopnik JM, Baldi L, Vogel M, Stadler BM,. Natural anti-FcepsilonRIalpha autoantibodies isolated from healthy donors and chronic idiopathic urticaria patients reveal a restricted repertoire and autoreactivity on human basophils. Hum Antibodies 2001; 10: 119-126.
24. Hide M, Francis DM, Grattan CE, Barr RM, Winkelmann RK, Greaves MW,. The pathogenesis of chronic idiopathic urticaria: new evidence suggests an auto-immune basis and implications for treatment. Clin Exp Allergy 1994; 24: 624-627.
25. Brunetti L, Francavilla R, Miniello VL, Platzer MH, Rizzi D, Lospalluti ML, et al. High prevalence of autoimmune urticaria in children with chronic urticaria. J Allergy Clin Immunol 2004; 114: 922-927.
26. Du Toit G, Prescott R, Lawrence P, Johar A, Brown G, Weinberg EG, et al. Autoantibodies to the high-affinity IgE receptor in children with chronic urticaria. Ann Allergy Asthma Immunol 2006; 96: 341-344.
27. Grattan CE, Walpole D, Francis DM, Niimi N, Dootson G, Edler S, et al. Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity. Clin Exp Allergy 1997; 27: 1417-1424.
28. Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza Black A, Greaves MW,. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999; 140: 446-452.
29. O'Donnell BF, O'Neill CM, Francis DM, Niimi N, Barr RM, Barlow RJ, et al. Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol 1999; 140: 853-858.
30. Asero R, Tedeschi A, Lorini M, Salimbeni R, Zanoletti T, Miadonna A,. Chronic urticaria: novel clinical and serological aspects. Clin Exp Allergy 2001; 31: 1105-1110.
31. Caproni M, Volpi W, Giomi B, Cardinali C, Antiga E, Melani L, et al. Chronic idiopathic and chronic autoimmune urticaria: clinical and immunopathological features of 68 subjects. Acta Derm Venereol 2004; 84: 288-290.
32. De Swerdt A, Van Den Keybus C, Kasran A, Cadot P, Neyens K, Coorevits L, et al. Detection of basophil-activating IgG autoantibodies in chronic idiopathic urticaria by induction of CD 63. J Allergy Clin Immunol 2005; 116: 662-667.
33. Tedeschi A, Lorini M, Asero R,. No evidence of increased serum substance P levels in chronic urticaria patients with and without demonstrable circulating vasoactive factors. Clin Exp Dermatol 2005; 30: 171-175.
34. Frezzolini A, Provini A, Teofoli P, Pomponi D, De Pita O,. Serum-induced basophil CD63 expression by means of a tricolour flow cytometric method for the in vitro diagnosis of chronic urticaria. Allergy 2006; 61: 1071-1077.
35. Szegedi A, Irinyi B, Gal M, Hunyadi J, Danko K, Kiss E, et al. Significant correlation between the CD63 assay and the histamine release assay in chronic urticaria. Br J Dermatol 2006; 155: 67-75.
36. Yasnowsky KM, Dreskin SC, Efaw B, Schoen D, Vedanthan PK, Alam R, et al. Chronic urticaria sera increase basophil CD203c expression. J Allergy Clin Immunol 2006; 117: 1430-1434.
37. Tedeschi A, Lorini M, Suli C, Asero R,. Serum interleukin-18 in patients with chronic ordinary urticaria: association with disease activity. Clin Exp Dermatol 2007; 32: 568-570.
38. Fagiolo U, Kricek F, Ruf C, Peserico A, Amadori A, Cancian M,. Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol 2000; 106: 567-572.
39. Piconi S, Trabattoni D, Iemoli E, Fusi ML, Villa ML, Milazzo F, et al. Immune profiles of patients with chronic idiopathic urticaria. Int Arch Allergy Immunol 2002; 128: 59-66.
40. Nettis E, Dambra P, D'Oronzio L, Cavallo E, Loria MP, Fanelli M, et al. Reactivity to autologous serum skin test and clinical features in chronic idiopathic urticaria. Clin Exp Dermatol 2002; 27: 29-31.
41. Confino-Cohen R, Aharoni D, Goldberg A, Gurevitch I, Buchs A, Weiss M, et al. Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria. J Allergy Clin Immunol 2002; 109: 349-356.
42. Bakos N, Hillander M,. Comparison of chronic autoimmune urticaria with chronic idiopathic urticaria. Int J Dermatol 2003; 42: 613-615.
43. Asero R, Lorini M, Chong SU, Zuberbier T, Tedeschi A,. Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells. Clin Exp Allergy 2004; 34: 1111-1114.
44. Bagenstose SE, Levin L, Bernstein JA,. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol 2004; 113: 134-140.
45. Godse KV,. Autologous serum skin test in chronic idiopathic urticaria. Indian J Dermatol Venereol Leprol 2004; 70: 283-284.
46. Gyimesi E, Sipka S, Danko K, Kiss E, Hidvegi B, Gal M, et al. Basophil CD63 expression assay on highly sensitized atopic donor leucocytes-a useful method in chronic autoimmune urticaria. Br J Dermatol 2004; 151: 388-396.
47. Reeves GE, Boyle MJ, Bonfield J, Dobson P, Loewenthal M,. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Intern Med J 2004; 34: 182-186.
48. Toubi E, Kessel A, Avshovich N, Bamberger E, Sabo E, Nusem D, et al. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy 2004; 59: 869-873.
49. Pachlopnik JM, Horn MP, Fux M, Dahinden M, Mandallaz M, Schneeberger D, et al. Natural anti-FcepsilonRIalpha autoantibodies may interfere with diagnostic tests for autoimmune urticaria. J Autoimmun 2004; 22: 43-51.
50. Fusari A, Colangelo C, Bonifazi F, Antonicelli L,. The autologous serum skin test in the follow-up of patients with chronic urticaria. Allergy 2005; 60: 256-258.
51. Asero R, Tedeschi A, Riboldi P, Cugno M,. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol 2006; 117: 1113-1117.
52. Garmendia JV, Zabaleta M, Aldrey O, Rivera H, De Sanctis JB, Bianco NE, et al. Immunophenotype characteristics of peripheral blood mononuclear leukocytes of chronic idiopathic urticaria patients. Invest Clin 2006; 47: 361-369.
53. Kulthanan K, Jiamton S, Gorvanich T, Pinkaew S,. Autologous serum skin test in chronic idiopathic urticaria: prevalence, correlation and clinical implications. Asian Pac J Allergy Immunol 2006; 24: 201-206.
54. Staubach P, Onnen K, Vonend A, Metz M, Siebenhaar F, Tschentscher I, et al. Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial. Dermatology 2006; 212: 150-159.
55. Lourenco FD, Azor MH, Santos JC, Prearo E, Maruta CW, Rivitti EA, et al. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus. Br J Dermatol 2008; 158: 979-986.
56. Mamatha G, Balachandran C, Smitha P,. Chronic idiopathic urticaria: Comparison of clinical features with positive autologous serum skin test. Indian J Dermatol Venereol Leprol 2008; 74: 105-108.
57. Nguyen KL, Gillis S, MacGlashan DW Jr,. A comparative study of releasing and nonreleasing human basophils: nonreleasing basophils lack an early component of the signal transduction pathway that follows IgE cross-linking. J Allergy Clin Immunol 1990; 85: 1020-1029.
58. Knol EF, Mul FP, Kuijpers TW, Verhoeven AJ, Roos D,. Intracellular events in anti-IgE nonreleasing human basophils. J Allergy Clin Immunol 1992; 90: 92-103.
59. Laidlaw TM, Steinke JW, Tinana AM, Feng C, Xing W, Lam BK, et al. Characterization of a novel human mast cell line that responds to stem cell factor and expresses functional FcepsilonRI. J Allergy Clin Immunol 2011; 127: 815-822 e815.
60. Wedi B, Novacovic V, Koerner M, Kapp A,. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression-inhibitory effects of anti-inflammatory drugs. J Allergy Clin Immunol 2000; 105: 552-560.
61. Ferrer M, Nunez-Cordoba JM, Luquin E, Grattan CE, De La Borbolla JM, Sanz ML, et al. Serum total tryptase levels are increased in patients with active chronic urticaria. Clin Exp Allergy 2010; 40: 1760-1766.
62. Vasagar K, Vonakis BM, Gober LM, Viksman A, Gibbons SP Jr, Saini SS,. Evidence of in vivo basophil activation in chronic idiopathic urticaria. Clin Exp Allergy 2006; 36: 770-776.
63. Gentinetta T, Pecaric-Petkovic T, Wan D, Falcone FH, Dahinden CA, Pichler WJ, et al. Individual IL-3 priming is crucial for consistent in vitro activation of donor basophils in patients with chronic urticaria. J Allergy Clin Immunol 2011; 128: 1227-1234 e1225.
64. Boumiza R, Monneret G, Forissier MF, Savoye J, Gutowski MC, Powell WS, et al. Marked improvement of the basophil activation test by detecting CD203c instead of CD63. Clin Exp Allergy 2003; 33: 259-265.
65. Knol EF, Mul FP, Jansen H, Calafat J, Roos D,. Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol 1991; 88 (3 Pt 1): 328-338.
66. Buhring HJ, Seiffert M, Giesert C, Marxer A, Kanz L, Valent P, et al. The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3. Blood 2001; 97: 3303-3305.
67. Altrich ML, Halsey JF, Altman LC,. Comparison of the in vivo autologous skin test with in vitro diagnostic tests for diagnosis of chronic autoimmune urticaria. Allergy Asthma Proc 2009; 30: 28-34.
68. Soundararajan S, Kikuchi Y, Joseph K, Kaplan AP,. Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol 2005; 115: 815-821.
69. Vonakis BM, Saini SS,. New concepts in chronic urticaria. Curr Opin Immunol 2008; 20: 709-716.
70. Grattan CE, Hamon CG, Cowan MA, Leeming RJ,. Preliminary identification of a low molecular weight serological mediator in chronic idiopathic urticaria. Br J Dermatol 1988; 119: 179-183.
71. Zweiman B, Valenzano M, Atkins PC, Tanus T, Getsy JA,. Characteristics of histamine-releasing activity in the sera of patients with chronic idiopathic urticaria. J Allergy Clin Immunol 1996; 98: 89-98.
72. Kikuchi Y, Kaplan AP,. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 2002; 109: 114-118.
73. Fureder W, Agis H, Willheim M, Bankl HC, Maier U, Kishi K, et al. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J Immunol 1995; 155: 3152-3160.
74. Luquin E, Kaplan AP, Ferrer M,. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy 2005; 35: 456-460.
75. Saini SS, Paterniti M, Vasagar K, Gibbons SP Jr, Sterba PM, Vonakis BM,. Cultured peripheral blood mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization: relationship to expression of Syk and SHIP-2. Clin Immunol 2009; 132: 342-348.
76. Jacques P, Lavoie A, Bedard PM, Brunet C, Hebert J,. Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission. J Allergy Clin Immunol 1992; 89: 1139-1143.
77. Grattan CE, Wallington TB, Warin RP, Kennedy CT, Bradfield JW,. A serological mediator in chronic idiopathic urticaria-a clinical, immunological and histological evaluation. Br J Dermatol 1986; 114: 583-590.
78. Kern F, Lichtenstein LM,. Defective histamine release in chronic urticaria. J Clin Invest 1976; 57: 1369-1377.
79. Cohen RW, Rosenstreich DL,. Discrimination between urticaria-prone and other allergic patients by intradermal skin testing with codeine. J Allergy Clin Immunol 1986; 77: 802-807.
80. Rorsman H,. Basophilic leucopenia in different forms of urticaria. Acta Allergol 1962; 17: 168-184.
81. Sabroe RA, Francis DM, Barr RM, Black AK, Greaves MW,. Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol 1998; 102 (4 Pt 1): 651-658.
82. Grattan CE, Dawn G, Gibbs S, Francis DM,. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin Exp Allergy 2003; 33: 337-341.
83. Caproni M, Giomi B, Volpi W, Melani L, Schincaglia E, Macchia D, et al. Chronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced wheals. Clin Immunol 2005; 114: 284-292.
84. Ying S, Kikuchi Y, Meng Q, Kay AB, Kaplan AP,. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol 2002; 109: 694-700.
85. Grattan CE, Boon AP, Eady RA, Winkelmann RK,. The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late-phase reactions. Int Arch Allergy Appl Immunol 1990; 93: 198-204.
86. James MP, Kennedy AR, Eady RA,. A microscopic study of inflammatory reactions in human skin induced by histamine and compound 48/80. J Invest Dermatol 1982; 78: 406-413.
87. Smith CH, Kepley C, Schwartz LB, Lee TH,. Mast cell number and phenotype in chronic idiopathic urticaria. J Allergy Clin Immunol 1995; 96: 360-364.
88. Sabroe RA, Seed PT, Francis DM, Barr RM, Black AK, Greaves MW,. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. J Am Acad Dermatol 1999; 40: 443-450.
89. Zuberbier T, Henz BM, Fiebiger E, Maurer D, Stingl G,. Anti-FcepsilonRIalpha serum autoantibodies in different subtypes of urticaria. Allergy 2000; 55: 951-954.
90. Harris A, Twarog FJ, Geha RS,. Chronic urticaria in childhood: natural course and etiology. Ann Allergy 1983; 51 (2 Pt 1): 161-165.
91. Asero R, Orsatti A, Tedeschi A, Lorini M,. Autoimmune chronic urticaria associated with type 1 diabetes and Graves' disease. J Allergy Clin Immunol 2005; 115: 1088-1089.
92. Dalal I, Levine A, Somekh E, Mizrahi A, Hanukoglu A,. Chronic urticaria in children: expanding the "autoimmune kaleidoscope". Pediatrics 2000; 106: 1139-1141.
93. Gaig P, Garcia-Ortega P, Enrique E, Richart C,. Successful treatment of chronic idiopathic urticaria associated with thyroid autoimmunity. J Investig Allergol Clin Immunol 2000; 10: 342-345.
94. Gallo C, Vighi G, Schroeder J, Strozzi M, Scibilia J, Colafrancesco M, et al. Chronic urticaria atopic dermatitis and celiac disease. Am J Gastroenterol 1992; 87: 1684.
95. Caminiti L, Passalacqua G, Magazzu G, Comisi F, Vita D, Barberio G, et al. Chronic urticaria and associated coeliac disease in children: a case-control study. Pediatr Allergy Immunol 2005; 16: 428-432.
96. Hautekeete ML, DeClerck LS, Stevens WJ,. Chronic urticaria associated with coeliac disease. Lancet 1987; 1: 157.
97. Asero R, Lorini M, Tedeschi A,. Association of chronic urticaria with thyroid autoimmunity and Raynaud phenomenon with anticentromere antibodies. J Allergy Clin Immunol 2003; 111: 1129-1130.
98. Leznoff A, Josse RG, Denburg J, Dolovich J,. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 1983; 119: 636-640.
99. Leznoff A, Sussman GL,. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989; 84: 66-71.
100. Turktas I, Gokcora N, Demirsoy S, Cakir N, Onal E,. The association of chronic urticaria and angioedema with autoimmune thyroiditis. Int J Dermatol 1997; 36: 187-190.
101. O'Donnell BF, Francis DM, Swana GT, Seed PT,. Kobza Black A, Greaves MW. Thyroid autoimmunity in chronic urticaria. Br J Dermatol 2005; 153: 331-335.
102. Verneuil L, Leconte C, Ballet JJ, Coffin C, Laroche D, Izard JP, et al. Association between chronic urticaria and thyroid autoimmunity: a prospective study involving 99 patients. Dermatology 2004; 208: 98-103.
103. Palma-Carlos AG, Palma-Carlos ML,. Chronic urticaria and thyroid auto-immunity. Eur Ann Allergy Clin Immunol 2005; 37: 143-146.
104. Cebeci F, Tanrikut A, Topcu E, Onsun N, Kurtulmus N, Uras AR,. Association between chronic urticaria and thyroid autoimmunity. Eur J Dermatol 2006; 16: 402-405.
105. Kikuchi Y, Fann T, Kaplan AP,. Antithyroid antibodies in chronic urticaria and angioedema. J Allergy Clin Immunol 2003; 112: 218.
106. Asero R,. Sex differences in the pathogenesis of chronic urticaria. J Allergy Clin Immunol 2003; 111: 425-426.
107. Magen E, Mishal J, Schlesinger M, Scharf S,. Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test. Helicobacter 2007; 12: 567-571.
108. Greaves MW,. Chronic Idiopathic Urticaria (CIU) and Helicobacter pylori. Not Directly Causative, But Could There Be a Link?. Allergy Clin Immunol Int 2001; 13: 23-26.
109. Ryhal B, DeMera RS, Shoenfeld Y, Peter JB, Gershwin ME,. Are autoantibodies present in patients with subacute and chronic urticaria? J Investig Allergol Clin Immunol 2001; 11: 16-20.
110. Toubi E, Adir-Shani A, Kessel A, Shmuel Z, Sabo E, Hacham H,. Immune aberrations in B and T lymphocytes derived from chronic urticaria patients. J Clin Immunol 2000; 20: 371-378.
111. Kessel A, Helou W, Bamberger E, Sabo E, Nusem D, Panassof J, et al. Elevated serum total IgE-a potential marker for severe chronic urticaria. Int Arch Allergy Immunol 2010; 153: 288-293.
112. Oztas P, Onder M, Gonen S, Oztas MO, Soylemezoglu O,. Is there any relationship between human leucocyte antigen class II and chronic urticaria? (chronic urticaria and HLA class II). Yonsei Med J 2004; 45: 392-395.
113. Aydogan K, Karadogan SK, Akdag I, Tunali S,. HLA class I and class II antigens in Turkish patients with chronic ordinary urticaria. Clin Exp Dermatol 2006; 31: 424-429.
114. Asero R,. Chronic idiopathic urticaria: a family study. Ann Allergy Asthma Immunol 2002; 89: 195-196.
115. Grattan CE, Francis DM, Slater NG, Barlow RJ, Greaves MW,. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 1992; 339: 1078-1080.
116. O'Donnell BF, Barr RM, Black AK, Francis DM, Kermani F, Niimi N, et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998; 138: 101-106.
117. Grattan CE, O'Donnell BF, Francis DM, Niimi N, Barlow RJ, Seed PT, et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol 2000; 143: 365-372.
118. Toubi E, Blant A, Kessel A, Golan TD,. Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy 1997; 52: 312-316.
119. Di Gioacchino M, Di Stefano F, Cavallucci E, Verna N, Ramondo S, Paolini F, et al. Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation. Allergy Asthma Proc 2003; 24: 285-290.
120. Vena GA, Cassano N, Colombo D, Peruzzi E, Pigatto P,. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol 2006; 55: 705-709.
121. Kessel A, Toubi E,. Cyclosporine-A in severe chronic urticaria: the option for long-term therapy. Allergy 2011; 65: 1478-1482.
122. Luo H, Chen H, Daloze P, Chang JY, St-Louis G, Wu J,. Inhibition of in vitro immunoglobulin production by rapamycin. Transplantation 1992; 53: 1071-1076.
123. Marsland AM, Soundararajan S, Joseph K, Kaplan AP,. Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria. Clin Exp Allergy 2005; 35: 554-559.
124. Shahar E, Bergman R, Guttman-Yassky E, Pollack S,. Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids. Int J Dermatol 2006; 45: 1224-1227.
125. Perez A, Woods A, Grattan CE,. Methotrexate: a useful steroid-sparing agent in recalcitrant chronic urticaria. Br J Dermatol 2010; 162: 191-194.
126. Asero R,. Oral cyclophosphamide in a case of cyclosporin and steroid-resistant chronic urticaria showing autoreactivity on autologous serum skin testing. Clin Exp Dermatol 2005; 30: 582-583.
127. Bernstein JA, Garramone SM, Lower EG,. Successful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamide. Ann Allergy Asthma Immunol 2002; 89: 212-214.
128. Asero R, Tedeschi A,. Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysis. J Investig Allergol Clin Immunol 2010; 20: 386-390.
129. Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK,. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol 2008; 122: 569-573.
130. Beck LA, Marcotte GV, MacGlashan D, Togias A, Saini S,. Omalizumab-induced reductions in mast cell Fce psilon RI expression and function. J Allergy Clin Immunol 2004; 114: 527-530.
131. Gomez G, Jogie-Brahim S, Shima M, Schwartz LB,. Omalizumab reverses the phenotypic and functional effects of IgE-enhanced Fc epsilonRI on human skin mast cells. J Immunol 2007; 179: 1353-1361.
132. Gober L, Sterba P, Eckman J, Saini S,. Effect of anti-IgE (omalizumab) in chronic idiopathic urticaria patients. J Allergy Clin Immunol 2008; 121: S147.
133. Grattan CEH, Francis DM,. Autoimmune Urticaria. In:, James WD, Cockerell CJ, Dzubow LM, Paller AS, Yancey KB,. editors. Advances in Dermatology. St Louis: Mosby Inc; 2000: 311-400.
134. Grattan CE, Winkelmann RK, Zollman PE,. Attempted passive transfer of a serum factor in chronic urticaria from human to monkey. Br J Dermatol 1989; 120: 853-856.
135. Grattan CE,. Evaluation of a Proinflammatory Serological Mediator in Chronic Urticaria [MD Thesis], University of Cambridge, 1996.
136. Fung-Leung WP, De Sousa-Hitzler J, Ishaque A, Zhou L, Pang J, Ngo K, et al. Transgenic mice expressing the human high-affinity immunoglobulin (Ig) E receptor alpha chain respond to human IgE in mast cell degranulation and in allergic reactions. J Exp Med 1996; 183: 49-56.
137. Jaffery G, Bell EB, Coleman JW,. Induction of an auto-anti-IgE response in rats. IV. Effects on mast cell degranulation. Immunology 1993; 78: 635-642.